Effects of freezing and azide treatment of in vitro human skin on the flux and metabolism of 8-methoxypsoralen

Skin Pharmacology and Physiology

Volumn 9, Issue 4, 1996, Pages 274-280

  Shaikh, Naureen A ^a   Ademola, John I ^a   Maibach, Howard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Azide; Human skin; Metabolism; Methoxypsoralen; Percutaneous permeation; Transdermal permeation

Indexed keywords

AZIDE; DRUG METABOLITE; METHOXSALEN;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG METABOLISM; DRUG PENETRATION; FEMALE; FREEZING; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SKIN PERMEABILITY; THIN LAYER CHROMATOGRAPHY;

ADULT; AZIDES; FREEZING; HUMANS; MALE; METHOXSALEN; MIDDLE AGED; SKIN;

EID: 0029741420     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000211425     Document Type: Article

References (15)

1. Idson B: Vehicle effects in percutaneous absorption. Drug Metab Rev 1993;14:207-222.
2. Singer EJ, Wcgman PC, Lehman MD: Barrier development, ultrastructure, and sulfhydryl content of the fetal epidermis. J Soc Cosmet Chem 1971;22:119-137.
3. Nochman RL, Esterly NB: Increased skin permeability in preterm infants. J Pediatr 1971;79: 628-632.
4. Bronaugh RL, Stewart RF: Methods for in vitro percutaneous absorption studies. IV. The flow-through diffusion cell. J Pharm Sci 1985;74:64-67.
5. Higo N, Hinz RS, Lau DT, Benet LZ, Guy RH: Cutaneous metabolism of nitroglycerine in vitro. I. Homogenized versus intact skin. Pharm Res 1992; 187-190.
6. Bronaugh RL, Stewart RF: Methods for in vitro percutaneous absorption studies. III. Hydrophobic compounds. J Pharm Sci 1984;73:1255-1258.
7. Musarrar J, Wani A: Quantitative immunoanalysis of promutagenic 8-hydroxy-2'-deoxyguanosine in oxidized DNA. Carcinogenesis 1994; 15:2037-2043.
8. Pathak MA, Dall’Acqua F, Rodi-gheiro G, Parris JA: Metabolism of psoralens. J Jnvest Dermatol 1974: 62:347-349.
9. Bronaugh RL, Stewart RF: Methods for in vitro percutaneous absorption studies. III. Hydrophobic compounds. J Pharm Sci 1984,73:1255-1258.
10. Skelly JP, Shah VP, Maibach HI, Guy R, Wester C, Flynn G, Yacobi A: FDA and AAPS Report of the Workshops on Principles and Practices of in vitro Percutaneous Penetration Studies: Relevance to Bioavailability and Bioequivalence. Pharm Res 1984;4:265-267.
11. Adcmola JI, Wester RC, Maibach HI: Absorption and metabolism of 2-chloro-2,6-diethyl-N-(butoxymeth-yl)acetanilide (Butachlor) in human skin in vitro. Toxicol Appi Pharmacol 1993;121:78-86.
12. Gilette JR, Jollow DR: Drug metabolism in liver; in Becker F (ed): The Liver: Normal and Abnormal Functions. New York, Dckker, 1976. pp 165-195.
13. Higo N, Hinz RS, Lau DT, Benet LZ, Guy RH: Cutaneous metabolism of nitroglycerine in vitro. 1. Homogenized versus intact skin. Pharm Res 1992;9:187-190.
14. Francour JML, Golden GM, Potts RO: Oleic acid: Its effects on stratum corneum lipids in relation to transdermal drug delivery. Pharm Res 1990;7:621-627.
15. Kikkoji T, Gumbleton M, Higo N, Guy RH, Benet LZ: Percutaneous penetration kinetics of nitroglycerine and its dinitrate metabolites across hairless mouse skin in vitro. Pharm Res 1991;8:1231-1271.